Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06170528 · ClinicalTrials.gov registry record · NA

ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT06170528: Completed NA study, sponsored by Florida State University.

NCT06170528 is a NA study that has completed, run by Florida State University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06170528, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to address the unmet care needs and reduce the care burdens for persons with ADRD (Alzheimer's Disease and Alzheimer's Disease Related Dementias) and their caregivers by providing monitoring of daily activities and gestures using audio and radio sensing, providing voice-based reminders intervention. In phase 1, dyads will participate in two focus groups will take 60 minutes per each. In Phase 2, AURA\_ALZ (connecting Audio and Radio Sensing Systems-Alzheimer's Disease) will deployed for two weeks at participants' home. At the end of the two weeks, usability, acceptability of the use of the system will be measured.

Primary Outcome

Usability Scale (rating from 1 to 5 with the higher score is better)adapted for the evaluation of AURA-ALZ will be administered to assess the usability of AURA-ALZ.

Interventions

  • DEVICE AURA_ALZ

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2022-11-16
Est. Completion 2024-07-31
Phase NA
Florida State University

219 total trials

What the finished NCT06170528 record still lists

NCT06170528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which AURA_ALZ is the first listed.

NCT06170528 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06170528 about?

NCT06170528 is a clinical study titled "ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD". The purpose of this study is to address the unmet care needs and reduce the care burdens for persons with ADRD (Alzheimer's Disease and Alzheimer's Disease Related Dementias) and their caregivers by providing monitoring of daily activities and gestures using audio and radio sensing, providing voice-...

What is the current status of trial NCT06170528?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2022-11-16. Estimated completion is 2024-07-31.

What interventions are being tested in trial NCT06170528?

The interventions under investigation include: AURA_ALZ (DEVICE).

Who is sponsoring clinical trial NCT06170528?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06170528's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06170528, the US trial registry maintained by the National Library of Medicine. NCT06170528 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.